Trial Profile
A Phase I, Single-Dose, Open-Label, Three-Period, Randomized, Crossover Study to Compare the Relative Bioavailability Between Two Tablet Formulations of ASP015K and to Assess the Food Effect on a New Formulation in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2012
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary)
- Indications Plaque psoriasis; Transplant rejection
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 09 Dec 2011 New trial record